4-Bromo-5,6,7,8-tetrahydro-[1,5]naphthyridine-2-carboxylic acid, 95.0%, 250mg

L(-)-sorbosa, mínimo 98 %, para bioquímica, 25 g, envase de plástico.

4-Chloronicotinic acid, 95.0%, 1g

(4-(1H-Imidazol-1-yl)phenyl)methanamine dihydrochloride, 95.0%, 1g

3,3'-Dibromo-5,5'-bis(trimethylsilyl)-2,2'-bithiophene>98.0%(GC)5g

1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole, 95.0%, 10g

Señales de obligación según ISO 7010, instrucciones de lectura obligatorias, 100 mm, 1 pieza

3-Chloro-5-(difluoromethoxy)aniline, 98%, 250mg

Ethyl 3-Amino-3-methylbutyrate Hydrochloride>98.0%(N)5g

N1-Benzyl-N2,N2-dimethyl-N1-(pyridin-2-yl)ethane-1,2-diamine hydrochloride, 95.0%, 250mg

Bis(aminomethyl)norbornane (mixture of isomers)>98.0%(T)500g

CYCLOBUTANAMINE, 3-(3,4-DIMETHOXYPHENOXY)-, HCL (1:1), TRANS-, 95.0%, 500mg

4-Chloro-2-formylphenylboronic acid, 98.0%, 1g